Enclomiphene is the trans-isomer of clomiphene citrate, a selective estrogen receptor modulator (SERM) long used in fertility medicine.
🔬 Studied for: Post-Cycle & Endogenous Testosterone Research
💊 Also studied for: Male Hypogonadism Research
🧪 Not FDA-approved — sold strictly for laboratory research
📈 No standardized human dosage established in published literature
Enclomiphene is the trans-isomer of clomiphene citrate, a selective estrogen receptor modulator (SERM) long used in fertility medicine. Isolating enclomiphene from the mixed-isomer clomiphene formulation has been studied specifically for its effects on testosterone without the estrogenic isomer (zuclomiphene) associated with clomiphene's side effects.
Enclomiphene blocks estrogen receptors in the hypothalamus, disrupting the negative-feedback signal that estrogen normally sends to suppress LH and FSH release — the pathway studied for restoring endogenous testosterone production, distinct from exogenous testosterone replacement.
These are effects Enclomiphene has been studied for in available preclinical and early research — not claims about guaranteed outcomes.
Enclomiphene has been researched for its ability to raise LH, FSH, and endogenous testosterone levels while preserving fertility and testicular function, which is why it is frequently discussed in post-cycle-therapy research contexts as an alternative to full SERMs like clomiphene.
Clinical trials have specifically studied enclomiphene as a potential treatment for secondary hypogonadism in men who wish to preserve fertility, an area where it has more targeted human trial data than many PCT-related compounds.
Doses studied in enclomiphene clinical trials and doses used in fertility-context clomiphene prescribing are documented in that respective literature; no FDA-approved standalone enclomiphene dosage exists for research use.
Compound X does not provide dosing recommendations. Enclomiphene is sold for laboratory research use only and is not intended for human consumption.
Clomiphene (containing enclomiphene) has an established human safety record from decades of fertility use, including known effects such as visual disturbances, mood changes, and hot flashes; standalone enclomiphene has been studied in more limited Phase 2 trials and has not received independent FDA approval as its own product.
No. Enclomiphene is not FDA-approved for any indication and is sold strictly as a research chemical, not a medication or dietary supplement.
Post-Cycle & Endogenous Testosterone Research — Enclomiphene has been researched for its ability to raise LH, FSH, and endogenous testosterone levels while preserving fertility and testicular function, which is why it is frequently discussed in post-cycle-therapy research contexts as an alternative to full SERMs like clomiphene.
In the US, UK, Canada and Australia, Enclomiphene is generally sold labeled "for research use only, not for human consumption." It is not approved as a dietary supplement or medication in any of these countries.
Enclomiphene clinical trial data is indexed on PubMed under "Enclomiphene citrate hypogonadism trial" and "trans-clomiphene testosterone."
Compare current prices, purity testing claims and coupon codes across every vendor Compound X tracks.
New guides, vendor comparisons and compound breakdowns every week.